CORE--TISSUE CULTURE
核心——组织培养
基本信息
- 批准号:6202589
- 负责人:
- 金额:$ 22.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-01 至 2000-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Epithelial cell cultures are instrumental in defining the pathophysiology
of CF. A Tissue Procurement and Cell Culture Core was established at the
University of North Carolina (UNC) in 1984, under the auspices of the
Cystic Fibrosis Foundation, to provide standardized cell cultures to CF
researchers. The Core has supported projects of the UNC Cystic Fibrosis
Research Center since 1988, and has increased its output and capabilities
to meet growing research demands. The Tissue Culture Core will support the
SCOR projects through three major functions.
1. Tissue procurement.
. Obtain nasal and lung tissue from normal, disease control, and cystic
fibrosis humans as sources of airway epithelial cells.
. Characterize donors with respect to diagnosis, demographic, and clinical
features essential to research uses.
2. Airway epithelial cell isolation and culture.
. Isolate epithelial cells from large and small airways of human, primate
and rodent lungs.
. Prepare and maintain primary epithelial cell cultures from define
airway regions.
. Prepare differentiated cultures from passaged, or cryopreserved and
thawed cells on substrates as dictated by investigator needs.
. Prepared and provide airway epithelial cell lines from gene knockout
mice.
3. Cell culture technical development.
. Optimize epithelial culture conditions to replicate the gene expression,
morphological differentiation, and ion and mucus secretory functions of
normal and CF large and small airways.
. Produce genetically manipulated, well-differentiated primary airway
epithelial cell cultures.
. Provide very high humidity culture environments needed to assess airway
surface liquid topography in the absence of evaporation artifacts.
上皮细胞培养有助于确定病理生理学
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES R YANKASKAS其他文献
JAMES R YANKASKAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES R YANKASKAS', 18)}}的其他基金
HUMAN SUBMUCOSAL GLAND AND BRONCHIOLAR SECRETIONS
人类粘膜下腺和细支气管分泌物
- 批准号:
6056422 - 财政年份:1996
- 资助金额:
$ 22.26万 - 项目类别:
HUMAN SUBMUCOSAL GLAND AND BRONCHIOLAR SECRETIONS
人类粘膜下腺和细支气管分泌物
- 批准号:
2031544 - 财政年份:1996
- 资助金额:
$ 22.26万 - 项目类别:
HUMAN SUBMUCOSAL GLAND AND BRONCHIOLAR SECRETIONS
人类粘膜下腺和细支气管分泌物
- 批准号:
2771585 - 财政年份:1996
- 资助金额:
$ 22.26万 - 项目类别:
HUMAN SUBMUCOSAL GLAND AND BRONCHIOLAR SECRETIONS
人类粘膜下腺和细支气管分泌物
- 批准号:
2519627 - 财政年份:1996
- 资助金额:
$ 22.26万 - 项目类别:
相似海外基金
Rapid detection of Pseudomonas aeruginosa in people with cystic fibrosis
快速检测囊性纤维化患者中的铜绿假单胞菌
- 批准号:
10103495 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Collaborative R&D
Rational optimization of combinatorial therapies for the treatment of rare cystic fibrosis variants
合理优化治疗罕见囊性纤维化变异的组合疗法
- 批准号:
10736732 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Pulmonary delivery of base editors for gene therapy of cystic fibrosis with nonsense mutations
肺部递送碱基编辑器用于无义突变囊性纤维化的基因治疗
- 批准号:
488681 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Operating Grants
Analysis of synthetic derivatives with reduced lipophilicity as candidate potentiators towards better treatment alternatives for Cystic Fibrosis
分析亲脂性降低的合成衍生物作为候选增效剂,以获得更好的囊性纤维化治疗替代方案
- 批准号:
481159 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Developing Gene Editing Therapeutics, Biodegradable Polymeric Delivery Vehicles, and High-throughput Platforms for the Treatment of Cystic Fibrosis
开发用于治疗囊性纤维化的基因编辑疗法、可生物降解的聚合物递送载体和高通量平台
- 批准号:
10836095 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
A Ginsenoside TMEM16A Potentiator for Cystic Fibrosis
人参皂苷 TMEM16A 治疗囊性纤维化的增效剂
- 批准号:
10574384 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Computationally-Inspired Design of Non-Viral Gene Delivery Vehicles for mRNA-Based Cystic Fibrosis Therapies
用于基于 mRNA 的囊性纤维化治疗的非病毒基因传递载体的计算启发设计
- 批准号:
10760605 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
- 批准号:
10716654 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Health Outcomes of Parents with Cystic Fibrosis (HOPe:CF)
患有囊性纤维化的父母的健康结果 (HOPe:CF)
- 批准号:
10581321 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Preparation for lung transplant discussions and decisions among people with cystic fibrosis
囊性纤维化患者肺移植讨论和决策的准备
- 批准号:
10657027 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:














{{item.name}}会员




